Literature DB >> 414276

Blockage of progesterone-induced release of luteinizing hormone and prolactin by d-amphetamine and fenfluramine in rats.

A O Donoso.   

Abstract

Subcutaneous administration of d-amphetamine at various doses (1.25, 2.5, and 5 mg/kg) decreased plasma luteinizing-hormone levels in ovariectomized rats primed with estradiol and injected with progesterone. In these animals prolactin levels decreased after injection of 0.6 and 1.25 mg/kg of d-amphetamine. No significant hormone modifications were detected in oavariectomized and ovariectomized estradiol-primed rats after injection of 2.5 mg/kg of d-amphetamine. Fenfluramine at doses of 25 mg/kg induced decreases of plasma LH and prolactin levels in ovariectomized estradiol- and progesterone-treated rats. A low dose of fenfluramine, 2.5 mg/kg, had no effect. It is concluded that d-amphetamine and fenfluramine are able to alter the facilitatory actions of progesterone on luteinizing hormone and prolactin release in ovariectomized estradiol-primed rats.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 414276     DOI: 10.1007/bf01457854

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  22 in total

1.  Elevation of 3, 4-dihydroxyphenylacetic acid concentrations in rat brain and stimulation of prolactin secretion by fenfluramine: evidence for antagonism at dopamine receptor sites.

Authors:  R W Fuller; K W Perry; J A Clemens
Journal:  J Pharm Pharmacol       Date:  1976-08       Impact factor: 3.765

2.  SEROTONIN SUPPRESSION OF LUTEINIZATION IN GONADOTROPHIN-TREATED, IMMATURE RATS.

Authors:  W K O'STEEN
Journal:  Endocrinology       Date:  1964-06       Impact factor: 4.736

3.  Involvement of neurones containing 5-hydroxytryptamine in the mechanism of prolactin release induced by oestrogen.

Authors:  L Caligaris; S Taleisnik
Journal:  J Endocrinol       Date:  1974-07       Impact factor: 4.286

4.  Inhibitory role of dopamine and 5-hydroxytryptamine in the sexual behaviour of female rats.

Authors:  B J Everitt; K Fuxe; T Hökfelt
Journal:  Eur J Pharmacol       Date:  1974-11       Impact factor: 4.432

5.  Effects of drugs that modify brain monoamine concentrations on plasma gonadotropin and prolactin levels in the rat.

Authors:  A O Donoso; W Bishop; C P Fawcett; L Krulich; S M McCann
Journal:  Endocrinology       Date:  1971-09       Impact factor: 4.736

Review 6.  The mechanism of action of fenfluramine.

Authors:  S Garattini; W Buczko; A Jori; R Samanin
Journal:  Postgrad Med J       Date:  1975       Impact factor: 2.401

7.  Evidence that the central action of amphetamine is mediated via catecholamines.

Authors:  L C Hanson
Journal:  Psychopharmacologia       Date:  1966

8.  Modifications of post-coital LH secretion and oestrous behaviour induced by drugs in ovariectomized rats.

Authors:  S T Broitman; A O Donoso
Journal:  J Reprod Fertil       Date:  1975-08

9.  Effects of intraventricular catecholamines on luteinizing hormone release in ovariectomized-steroid-primed rats.

Authors:  R J Krieg; C H Sawyer
Journal:  Endocrinology       Date:  1976-08       Impact factor: 4.736

10.  Role of brain monoamines in release of gonadotropin before proestrus in the cyclic rat.

Authors:  E Terasawa; W E Bridson; J W Davenport; R W Goy
Journal:  Neuroendocrinology       Date:  1975       Impact factor: 4.914

View more
  2 in total

1.  Effect of d- and l-amphetamine on rat plasma prolactin levels.

Authors:  H Y Meltzer; R G Fessler; M Simonovic; J Doherty; V S Fang
Journal:  Psychopharmacology (Berl)       Date:  1979-03-14       Impact factor: 4.530

2.  The interaction between female sex hormones and D-amphetamine on central biogenic amines during the rat oestrous cycle.

Authors:  J M Fludder; S R Tonge
Journal:  Ir J Med Sci       Date:  1978-08       Impact factor: 1.568

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.